selected publications
-
academic article
-
Nisbet I. Cancer immunotherapy comes of age (Finally!).
Australasian Biotechnology.
26:38-40.
2016
-
Nisbet I. Biodiscovery of rich source of drug-like potent molecules-venom peptides.
Industrial Bioprocessing.
30:8-9.
2008
-
Nisbet I. The pharmaceutical forecast.
Australian Life Scientist.
2:16.
2005
-
Woodrow GCNisbet ICorbett ME. Australia: Ready for business.
Nature Biotechnology.
15:731-732.
1997
Full text if available -
Webb ETkalcevic JEdwards SHocking DNisbet I. Enhanced secretory ability for the human factor VIII light chain produced in baculovirus-infected insect cells.
Cytotechnology: international journal of cell culture and biotechnology.
21:165-170.
1996
Full text if available -
Jagadish MNEdwards SJHayden MBGrusovin JVandenberg KSchoofs PHamilton RCShukla DDKalnins HMcNamara MHaynes JNisbet ITWard CWPye D. Chimeric Potyvirus-Like Particles as Vaccine Carriers.
Intervirology: international journal of basic and medical virology.
39:85-92.
1996
Full text if available -
Ba-Thein WLyristis MOhtani KNisbet ITHayashi HRood JIShimizu T. The virR/virS locus regulates the transcription of genes encoding extracellular toxin production in Clostridium perfringens..
Journal of Bacteriology.
178:2514-2520.
1996
Full text if available -
Edwards SJHayden MBHamilton RCHaynes JANisbet ITJagadish MN. High level production of potyvirus-like particles in insect cells infected with recombinant baculovirus.
Archives of Virology.
136:375-380.
1994
Full text if available -
Lyristis MBryant AESloan JAwad MMNisbet ITStevens DLRood JI. Identification and molecular analysis of a locus that regulates extracellular toxin production in Clostridium perfringens.
Molecular Microbiology.
12:761-777.
1994
Full text if available -
Jagadish MNHamilton RCFernandez CSSchoofs PDavern KMKalnins HWard CWNisbet IT. High Level Production of Hybrid Poty virus–like Particles Carrying Repetitive Copies of Foreign Antigens in Escherichia coli.
Biotechnology.
11:1166-1170.
1993
Full text if available -
Webb ENisbet I. The effect on recombinant protein production of reinstating native introns in the coding sequence of human factor VIII.
Biotechnology Letters.
15:889-894.
1993
Full text if available -
Haynes JATkalcevic JNisbet IT. Production of an enzymatically inactive analog of phospholipase D from Corynebacterium pseudotuberculosis.
Gene.
119:119-121.
1992
Full text if available -
Wright IGCasu RCommins MADalrymple BPGale KRGoodger BVRiddles PWWaltisbuhl DJAbetz IBerrie DABowles YDimmock CHayes TKalnins HLeatch GMcCrae RMontague PENisbet ITParrodi FPeters JMScheiwe PCSmith WRode-Bramanis KWhite MA. The development of a recombinant Babesia vaccine.
Veterinary Parasitology.
44:3-13.
1992
Full text if available -
Glare EMPaton JCPremier RRLawrence AJNisbet IT. Analysis of a repetitive DNA sequence from Bordetella pertussis and its application to the diagnosis of pertussis using the polymerase chain reaction..
Journal of Clinical Microbiology.
28:1982-1987.
1990
Full text if available -
Hodgson ALBird PNisbet IT. Cloning, nucleotide sequence, and expression in Escherichia coli of the phospholipase D gene from Corynebacterium pseudotuberculosis..
Journal of Bacteriology.
172:1256-1261.
1990
Full text if available -
BEILHARZ MWNISBET ITTYMMS MJHERTZOG PJLINNANE AW. Antiviral and Antiproliferative Activities of Interferon-α1: The Role of Cysteine Residues.
Journal of Interferon Research.
6:677-685.
1986
Full text if available -
Nisbet ITBeilharz MWHertzog PJTymms MJLinnane AW. Single amino acid substititons at conserved residues of human interferon-α can effect antiviral specific activity.
Biochemistry International.
11:301-309.
1985
-
Nisbet ITBeilharz MW. Simplified DNA manupulations based on in vitro mutagenesis.
Gene Analysis Techniques.
2:23-29.
1985
Full text if available -
Linnane AWBeilharz MWMcMullen GLMacreadie IGMurphy MNisbet ITNovitski CEWoodrow GC. Nucleotide sequence and expression in E. coli of a human interferon-alpha gene selected from a genomic library using synthetic oligonucleotides..
Biochemistry International.
8:725-732.
1984
-
Nisbet I. Cancer immunotherapy comes of age (Finally!).
Australasian Biotechnology.
26:38-40.
2016